Introduction: Recent evidence suggests that oxytocin, a nonapeptide posited to underlie the affiliation-related "tend-and-befriend" behavioral response to stress (Taylor et al., 2000), may improve interpersonal functioning by facilitating the acquisition of social support during times of distress. The assertion, however, has not been explicitly tested in humans. Thus, we examined whether the effect of oxytocin on self-perceived trust is magnified in individuals who experienced higher ratings of negative mood following social rejection.
Method: In a double-blind experiment, 100 students (50 ♀) were subject to a live social rejection paradigm following random assignment to either a 24 IU intranasal oxytocin or placebo administration. Mood and self-perceived trust were measured following social rejection.
Results: Multiple regression and simple slope analysis revealed that oxytocin administration increased self-perceived trust relative to placebo in participants reporting a negative mood response following social rejection [b=4.245, t(96)=3.10, p=.003], but not in those whose mood state was euthymic.
Conclusion: These results demonstrate that oxytocin may promote the acquisition of social support in times of distress by increasing self-perceived trust. The findings provide empirical support that oxytocin promotes an affiliation-related behavioral response to stress, consistent with the tend-and-befriend theory.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.psyneuen.2013.05.006 | DOI Listing |
Trans R Soc Trop Med Hyg
December 2024
Department of Health Policy and Vanderbilt Institute for Global Health, Vanderbilt University Medical Center, Nashville, TN 37203, USA.
Background: There is a dearth of information regarding mpox risk perception and vaccine acceptance among people living with human immunodeficiency virus (HIV), especially in countries with a dual burden of HIV and mpox, such as Nigeria.
Methods: We used an explanatory mixed methods design and structured questionnaires administered to a clinic-based sample of people living with HIV (n=430), followed by in-depth interviews with a purposive subsample (n=20). Data were analysed using binary logistic regression and the framework approach.
J Clin Med
December 2024
Department of Gynaecology, Division of Gynaecology, Poznan University of Medical Sciences, 61-701 Poznan, Poland.
This study aims to evaluate the prevalence of premenstrual syndrome (PMS) among Polish adolescents and explore its associations with mental health outcomes, lifestyle factors, and risk behaviours. Additionally, it seeks to examine the impact of PMS on quality of life, contributing to the foundation for initiatives that enhance adolescent menstrual health. This research is part of the POLKA 18 study, a youth-led cross-sectional survey conducted between April and December 2019.
View Article and Find Full Text PDFSleep Med
January 2025
Healthy Active Living and Obesity Research Group, Children's Hospital of Eastern Ontario Research Institute, Ottawa, ON, Canada; Alliance for Research in Exercise, Nutrition and Activity (ARENA), University of South Australia, Adelaide, Australia; Centre for Surveillance and Applied Research, Public Health Agency of Canada, Ottawa, ON, Canada; School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada.
Front Med (Lausanne)
October 2024
Department of Clinical Pharmacy, Erasmus MC, Rotterdam, Netherlands.
Background: An open organizational culture in the workplace represents an environment where information, ideas, and feedback are freely exchanged among all members, regardless of position or rank. Currently, there are no valid survey instruments to measure this culture within a healthcare context. To address this gap, we developed a survey instrument to measure self-perceived open organizational culture at a university pharmacy using a test re-test study design.
View Article and Find Full Text PDFClin Transl Sci
October 2024
Department of Pharmacology, Oslo University Hospital, Oslo, Norway.
Statin-associated muscle symptoms are frequently reported and often lead to discontinuation of statin therapy with an increased risk of cardiovascular events. In vitro studies suggest that statin-mediated inhibition of the mevalonate pathway leads to muscle cell toxicity. We aimed to determine the relationship between mevalonate, LDL-cholesterol, and atorvastatin metabolites in patients with coronary heart disease and self-perceived muscle side effects.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!